Zhang · Nutrients 2022 · Double-blind, randomized, placebo-controlled trial · n=109

A Magtein ® , Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults.

Cited 35 times in the scientific literature.

Level 2 - randomized trial

Individual double-blind randomized controlled trial

PubMed 36558392 · doi:10.3390/nu14245235 · record verified 2026-08-31

What was done

In a double-blind, placebo-controlled trial, 109 healthy Chinese adults aged 18-65 years were randomly assigned to receive either 2 g/day of Magtein PS (a formulation of magnesium L-threonate, phosphatidylserine, vitamin C, and vitamin D) or a starch placebo for 30 days. Cognitive performance was evaluated at baseline and day 30 using the standardized Clinical Memory Test.

What was found

Participants receiving the active formula demonstrated significant improvements compared to the placebo group in all five subcategories of the Clinical Memory Test and in the overall memory quotient score. Older participants showed greater relative improvements than younger participants. The abstract does not report exact numerical scores, confidence intervals, or p-values.

Why it matters

This study provides randomized trial evidence that a magnesium L-threonate-containing supplement can support short-term memory performance in healthy adults.

Limits

The intervention combined magnesium L-threonate with phosphatidylserine and vitamins C and D, making it impossible to isolate the specific contribution of magnesium L-threonate. The trial had a short follow-up period (30 days), a single-country cohort, and the abstract omits quantitative effect sizes and statistical values.

Cited by